Congress quietly strips vaccine makers' legal shields, opens unlimited COVID liability

What it does

This bill creates new criminal penalties for vaccine manufacturers and clinical trial sponsors who make false statements or hide material data from federal agencies during vaccine trials. It also carves out exceptions to liability protections for vaccine makers if fraud is found, allowing injured parties to sue in federal court and receive damages without reduction from other awards, and explicitly extends this right to COVID-19 vaccine claims with no statute of limitations.

Why we flagged it

The bill's operative mechanism is not primarily criminal enforcement of fraud (which is already illegal); it is the removal of liability shields from vaccine manufacturers and the creation of unlimited civil liability for COVID-19 vaccines. The fraud language is the stated justification, but the actual effect is a targeted liability regime.

What the text implies

• The bill defines 'fraudulent material statement' nowhere in the text, leaving the Secretary of HHS sole discretion to determine what constitutes fraud after a hearing with only 5 days' notice to the manufacturer. This creates regulatory uncertainty and potential for inconsistent enforcement.
• Section 7(3) creates unlimited civil liability for COVID-19 vaccines with no statute of limitations ('at any time'), while other vaccines retain normal limitations. This retroactive, time-unlimited exposure may expose manufacturers to decades of claims.
• The bill allows plaintiffs to seek compensation under the National Vaccine Injury Compensation Program AND simultaneously sue in federal court for the same injury, with damages not reduced by awards from either forum. This creates double-recovery potential.
• Removal of liability protections under the Public Health Service Act (Section 6) and Right to Try Act (Section 5) applies retroactively to all prior clinical trials, potentially reopening settled claims and creating liability for historical data.
• The 30-day refutation period (Section 8) and requirement to publish all testimony online may expose proprietary trial data and manufacturing information to public disclosure, creating competitive harm beyond the liability itself.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill creates accountability for fraud in vaccine trials—a genuine public protection—but simultaneously strips liability protections from vaccine manufacturers in ways that may chill vaccine development and increase litigation risk without clear evidentiary standards for what constitutes 'fraudulent material statements.' The carve-out for COVID-19 vaccines with no time limit and concurrent civil/compensation claims creates open-ended liability exposure that could deter future vaccine innovati

Who stands to gain

• plaintiff's bar / personal injury litigation firms
• vaccine injury claimants

Named in the bill

Moderna (MRNA), Pfizer, Johnson & Johnson, AstraZeneca, vaccine manufacturers, clinical trial sponsors, Secretary of Health and Human Services, National Vaccine Injury Compensation Program, Federal Food, Drug, and Cosmetic Act, Public Health Service Act, Right to Try Act

Where it stands

• May 29, 2025 — Introduced · Congress.gov: “Introduced in House”
• May 29, 2025 — Referred to House Committee on the Judiciary and House Committee on Energy and Commerce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a…”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.